1.         Park, H.L. and L.S. Kim, The current role of vacuum assisted breast biopsy system in breast disease. J Breast Cancer. 14(1): p. 1-7.

2.         O'Flynn, E.A., A.R. Wilson, and M.J. Michell, Image-guided breast biopsy: state-of-the-art. Clin Radiol. 65(4): p. 259-70.

3.         Robin Leake (Biochemistry, G., Diana Barnes (Pathology, Guy’s Hospital, London), Sarah Pinder and Ian Ellis (Pathology, Nottingham), Liz Anderson (Clinical Research, Christie Hospital, Manchester), Tom Anderson (Pathology, Edinburgh), Ruth Adamson (Pathology, Kilmarnock), Tony Rhodes and Keith Miller (UK NEQAS) and Rosemary Walker (Pathology, Leicester). GUIDELINES FOR NON-OPERATIVE DIAGNOSTIC PROCEDURES AND REPORTING IN BREAST CANCER SCREENING

NHSBSP Publication, 2001. 50.

4.         Andreu, F.J., et al., Breast core biopsy reporting categories--An internal validation in a series of 3054 consecutive lesions. Breast, 2007. 16(1): p. 94-101.

5.         Zenklusen, S.D.L.B.H.-A.L.B.L.H.-R. (2011) Qualitätsrichtlinien der schweizerischen Gesellschaft für Pathologie SGPath.  Volume, 

6.         O.R. Köchli, J.C.R., R. Brun del Re, M. Bürge, R. Caduff, K. and C.O. Kinkel, Bildgesteuerte minimalinvasive Mammaeingriffe: Konsensusstatements für die Schweizerische Gesellschaft für Senologie (SGS) und die Arbeitsgruppe „Bildgesteuerte minimalinvasive Mammaeingriffe. Senologie - Zeitschrift für Mammadiagnostik und -therapie, 2009. 6: p. 181-184.

7.         Bianchi, S., et al., Diagnostic concordance in reporting breast needle core biopsies using the B classification-A panel in Italy. Pathol Oncol Res, 2009. 15(4): p. 725-32.

8.         Quinn, B.D.H.C.M., Pathology of B3 lesions of the breast. DIAGNOSTIC HISTOPATHOLOGY, 2009.

9.         Bianchi, S., et al., Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in Italy. Breast. 20(3): p. 264-70.

10.       Dillon, M.F., et al., Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy. Ann Surg Oncol, 2007. 14(2): p. 704-11.

11.       El-Sayed, M.E., et al., Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Histopathology, 2008. 53(6): p. 650-7.

12.       Hayes, B.D., A. O'Doherty, and C.M. Quinn, Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience. J Clin Pathol, 2009. 62(12): p. 1136-40.

13.       Houssami, N., et al., Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3). Br J Cancer, 2007. 96(8): p. 1253-7.

14.       Kumaroswamy, V., J. Liston, and A.M. Shaaban, Vacuum assisted stereotactic guided mammotome biopsies in the management of screen detected microcalcifications: experience of a large breast screening centre. J Clin Pathol, 2008. 61(6): p. 766-9.

15.       Lee, A.H., et al., Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3). Histopathology, 2003. 42(4): p. 331-6.

16.       Lieske, B., et al., Screen-detected breast lesions with an indeterminate (B3) core needle biopsy should be excised. Eur J Surg Oncol, 2008. 34(12): p. 1293-8.

17.       Noske, A., et al., Flat epithelial atypia is a common subtype of B3 breast lesions and is associated with noninvasive cancer but not with invasive cancer in final excision histology. Hum Pathol. 41(4): p. 522-7.

18.       Regine Rathmann (1), B.R., Franco Caldarone (1), and Peter Landwehr (3), B3-Läsionen im Mammographie-

Screening – Ergebnisse der Screening-

Einheit Hannover/Schaumburg. Deutschen Gesellschaft für Senologie, 2010. 5.

19.       Georgian-Smith, D. and T.J. Lawton, Variations in physician recommendations for surgery after diagnosis of a high-risk lesion on breast core needle biopsy. AJR Am J Roentgenol. 198(2): p. 256-63.

20.       Schweizerischen, A.M.I.B.M.d. and G.f.S. (SGS), AUFKLÄRUNGSPROTOKOLL ZUR MRI-GESTEUERTEN MINIMALINVASIVEN BRUSTBIOPSIE (Vakuumbiopsie). 2008.

21.       Schweizerischen, A.M.I.B.M.d. and G.f.S. (SGS), AUFKLÄRUNGSPROTOKOLL ZUR STEREOTAKTISCHEN MINIMALINVASIVE

BRUSTBIOPSIE (Vakuumbiopsie). 2011.

22.       Schweizerischen, A.M.I.B.M.d. and G.f.S. (SGS), AUFKLÄRUNGSPROTOKOLL ZUR ULTRASCHALL-GESTEUERTEN

MINIMAL-INVASIVE BRUSTBIOPSIE (Vakuumbiopsie. 2011.

23.       I O Ellis, S.H., M Michell, S E Pinder, C A Wells, H D Zakhour, Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. June 2001, NHSBSP Publication. p. 60.

24.       Wallis, M., et al., Guidelines from the European Society of Breast Imaging for diagnostic interventional breast procedures. Eur Radiol, 2007. 17(2): p. 581-8.

25.       Albert, U.-S., Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland. W. Zuckschwerdt Verlag München · Wien · New York, 2008.

26.       Eby, P.R. and C.D. Lehman, Magnetic resonance imaging--guided breast interventions. Top Magn Reson Imaging, 2008. 19(3): p. 151-62.

27.       Vandromme, M.J., H. Umphrey, and H. Krontiras, Image-guided methods for biopsy of suspicious breast lesions. J Surg Oncol. 103(4): p. 299-305.

28.       Perry, N., et al., European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document. Ann Oncol, 2008. 19(4): p. 614-22.

29.       O, L.S.R.E.I., WHO Classification of Tumours of the Breast WHO blue book series. 2012.

30.       Pathology and Genetics of Tumours of the Breast and Female Genital Organs. 2003 ed. 2003.

31.       Ibrahim, A.E., et al., The role and histological classification of needle core biopsy in comparison with fine needle aspiration cytology in the preoperative assessment of impalpable breast lesions. J Clin Pathol, 2001. 54(2): p. 121-5.

32.       Pagni, F., et al., Application of the British National Health Service Breast Cancer Screening Programme classification in 226 breast core needle biopsies: correlation with resected specimens. Ann Diagn Pathol. 16(2): p. 112-8.

33.       Rajan, S., et al., New patient pathway using vacuum-assisted biopsy reduces diagnostic surgery for B3 lesions. Clin Radiol. 67(3): p. 244-9.

34.       Tonegutti, M., et al., B3 breast lesions determined by vacuum-assisted biopsy: how to reduce the frequency of benign excision biopsies. Radiol Med. 115(8): p. 1246-57.

35.       Weigel, S., et al., Minimal invasive biopsy results of "uncertain malignant potential" in digital mammography screening: high prevalence but also high predictive value for malignancy. Rofo. 183(8): p. 743-8.

36.       Liberman, L., et al., Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy. AJR Am J Roentgenol, 2007. 188(3): p. 684-90.

37.       Begum, S.M., et al., Mucin extravasation in breast core biopsies--clinical significance and outcome correlation. Histopathology, 2009. 55(5): p. 609-17.

38.       Jara-Lazaro, A.R., G.M. Tse, and P.H. Tan, Columnar cell lesions of the breast: an update and significance on core biopsy. Pathology, 2009. 41(1): p. 18-27.

39.       McGhan, L.J., et al., Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy? Ann Surg Oncol. 19(10): p. 3264-9.

40.       Sydnor, M.K., et al., Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy. Radiology, 2007. 242(1): p. 58-62.

41.       Johnson, N.B. and L.C. Collins, Update on percutaneous needle biopsy of nonmalignant breast lesions. Adv Anat Pathol, 2009. 16(4): p. 183-95.

42.       Carder, P.J., et al., Large volume "mammotome" biopsy may reduce the need for diagnostic surgery in papillary lesions of the breast. J Clin Pathol, 2008. 61(8): p. 928-33.

43.       Tennant, S.L., et al., Vacuum-assisted excision of breast lesions of uncertain malignant potential (B3) - an alternative to surgery in selected cases. Breast, 2008. 17(6): p. 546-9.

44.       Lu, Q., et al., Surgical excision of intraductal breast papilloma diagnosed on core biopsy. ANZ J Surg. 82(3): p. 168-72.

45.       Brookes, M.J. and A.G. Bourke, Radiological appearances of papillary breast lesions. Clin Radiol, 2008. 63(11): p. 1265-73.

46.       Rizzo, M., et al., Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical follow-up. J Am Coll Surg. 214(3): p. 280-7.

47.       Pinder, S.E. and J.S. Reis-Filho, Non-operative breast pathology: columnar cell lesions. J Clin Pathol, 2007. 60(12): p. 1307-12.

48.       Moinfar, F., Flat ductal intraepithelial neoplasia of the breast: a review of diagnostic criteria, differential diagnoses, molecular-genetic findings, and clinical relevance--it is time to appreciate the Azzopardi concept! Arch Pathol Lab Med, 2009. 133(6): p. 879-92.

49.       Chivukula, M., et al., Clinicopathologic implications of "flat epithelial atypia" in core needle biopsy specimens of the breast. Am J Clin Pathol, 2009. 131(6): p. 802-8.

50.       Cangiarella, J., et al., Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literature. Arch Pathol Lab Med, 2008. 132(6): p. 979-83.

51.       Destounis, S.V., et al., Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility. AJR Am J Roentgenol. 198(2): p. 281-7.

52.       Hwang, H., et al., Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. Mod Pathol, 2008. 21(10): p. 1208-16.

53.       Douglas-Jones, A.G. and D.P. Pace, Pathology of R4 spiculated lesions in the breast screening programme. Histopathology, 1997. 30(3): p. 214-20.

54.       Mokbel, K., et al., Radial scar and carcinoma of the breast: microscopic findings in 32 cases. Breast, 1999. 8(6): p. 339-42.

55.       Sloane, J.P. and M.M. Mayers, Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology, 1993. 23(3): p. 225-31.

56.       Wilson R, A.D., Cooke J, Michell M, Patrick J. , Clinical Guidelines for breast screening assessment. Sheffield: NHS cancer Screening Programmes. 2001.

57.       Houssami, N., et al., Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer, 2007. 109(3): p. 487-95.

58.       Reefy, S., et al., Surgical excision for B3 breast lesions diagnosed by vacuum-assisted core biopsy. Anticancer Res. 30(6): p. 2287-90.

59.       Costarelli, L., et al., Intraductal proliferative lesions of the breast-terminology and biology matter: premalignant lesions or preinvasive cancer? Int J Surg Oncol. 2012: p. 501904.